CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project investigates the role of immune cells in the early stages of Parkinson's disease, focusing on how they contribute to the spread of alpha-synuclein pathology. It aims to identify new biomarkers and therapeutic targets for early intervention.
Parkinson’s disease (PD) is a progressive neurodegenerative disorder, characterized by alpha-synuclein (α-Syn) aggregation.
Despite being the fastest-growing neurodegenerative condition in terms of patients affected, there are currently no disease-modifying treatments and diagnosis typically occurs after significant neurodegeneration has already taken place.
Intervening in the prodromal phase remains the critical challenge, and gaining a deeper understanding of the underlying pathophysiology is…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
